NextCure, Inc. Share Price
NXTCNextCure, Inc. Stock Performance
Open $9.86 | Prev. Close $9.81 | Circuit Range N/A |
Day Range $9.86 - $9.86 | Year Range $0.40 - $15.61 | Volume 174 |
Average Traded $9.86 |
NextCure, Inc. Share Price Chart
About NextCure, Inc.
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NextCure, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-May-26 | $9.81 | $9.81 | +0.26% |
11-May-26 | $9.79 | $9.79 | -0.71% |
08-May-26 | $9.86 | $9.86 | -1.55% |
07-May-26 | $10.47 | $10.01 | -5.57% |
06-May-26 | $9.09 | $10.60 | +18.30% |
04-May-26 | $9.42 | $8.96 | -6.23% |
01-May-26 | $9.80 | $9.55 | +2.19% |
FAQs on NextCure, Inc. Share Price
Can I buy NextCure, Inc. shares in India?
What is the share price of NextCure, Inc.?
What is the 5 year returns of NextCure, Inc.?
What are the high & low stock price of NextCure, Inc. today?
What is the 52-week high and low of NextCure, Inc. stock?